Lonafarnib
In Stock•Starting at $26 for 1 mg•Purity ≥ 98%
| CAS No. | 193275-84-2 |
|---|---|
| MDL No. | MFCD06795138 |
| MF | C27H31Br2ClN4O2 |
| MW | 638.80 |
| InChI Key | DHMTURDWPRKSOA-RUZDIDTESA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $26 | In Stock | |
| 5 mg | 98% | $79 | In Stock | |
| 10 mg | 98% | $118 | In Stock | |
| 25 mg | 98% | $198 | In Stock | |
| 50 mg | 98% | $314 | In Stock |
Product Information
Lonafarnib is a 4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamide with R configuration. It is an oral farnesyltransferase inhibitor used as an antineoplastic agent and EC 2.5.1.58 (protein farnesyltransferase) inhibitor.
| CAS No. | 193275-84-2 |
|---|---|
| Product Name | Lonafarnib |
Biological Targets
FNTA·FNTB
Associated Conditions
chronic myelomonocytic leukemia·urethra cancer·hepatitis D virus infection·chronic myelogenous leukemia·breast cancer·
* The information provided here is compiled from public sources and is for reference only.